Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Wigal, TL"'
Autor:
Volkow, ND, Wang, GJ, Newcorn, JH, Kollins, SH, Wigal, TL, Telang, F, Fowler, JS, Goldstein, RZ, Klein, N, Logan, J, Wong, C, Swanson, JM
Publikováno v:
Volkow, ND; Wang, GJ; Newcorn, JH; Kollins, SH; Wigal, TL; Telang, F; et al.(2011). Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Molecular Psychiatry, 16(11), 1147-1154. doi: 10.1038/mp.2010.97. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8m80p77v
Attention-deficit hyperactivity disorder (ADHD) is typically characterized as a disorder of inattention and hyperactivity/impulsivity but there is increasing evidence of deficits in motivation. Using positron emission tomography (PET), we showed decr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::953f6b5cc83a64490bcc345c8c717272
http://www.escholarship.org/uc/item/8m80p77v
http://www.escholarship.org/uc/item/8m80p77v
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Child & Adolescent Psychopharmacology; 2012 Jun, Vol. 22 Issue 3, p206-214, 9p
Autor:
Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y, Pradhan K, Wong C, Swanson JM, Volkow, Nora D, Wang, Gene-Jack, Kollins, Scott H, Wigal, Tim L, Newcorn, Jeffrey H, Telang, Frank, Fowler, Joanna S
Publikováno v:
JAMA: Journal of the American Medical Association; 2009 Sep 9, Vol. 302 Issue 10, p1084-1091, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wigal TL; AVIDA Inc., 1600 Dove Street, Suite 305, Newport Beach, CA, 92660, USA. drtim@avidainc.com., Newcorn JH; Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, 10029-5674, USA., Handal N; Dothan Behavioral Medicine Clinic, Harmonex Neuroscience Research, 408 Healthwest Drive, Dothan, AL, 36303, USA., Wigal SB; AVIDA Inc., 1600 Dove Street, Suite 305, Newport Beach, CA, 92660, USA., Mulligan I; Worldwide Clinical Trials, Waterfront House, Beeston Business Park, Beeston, Nottingham, NG9 1LA, UK., Schmith V; Nuventra Pharma Sciences, 2525 Meridian Parkway, Suite 280, Durham, NC, 27713, USA., Konofal E; Pediatric Sleep Disorders Center, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris (APHP), 48 Boulevard Serurier, Paris, France.
Publikováno v:
CNS drugs [CNS Drugs] 2018 Mar; Vol. 32 (3), pp. 289-301.
Autor:
Gehricke JG; Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; The Center for Autism & Neurodevelopmental Disorders, Santa Ana, CA 92705, USA. Electronic address: jgehrick@uci.edu., Swanson JM; Department of Pediatrics, University of California, Irvine, Irvine, CA, USA., Duong S; Department of Pediatrics, University of California, Irvine, Irvine, CA, USA., Nguyen J; The Center for Autism & Neurodevelopmental Disorders, Santa Ana, CA 92705, USA., Wigal TL; Department of Pediatrics, University of California, Irvine, Irvine, CA, USA., Fallon J; Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA, USA., Caburian C; The Center for Autism & Neurodevelopmental Disorders, Santa Ana, CA 92705, USA., Muftuler LT; Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI, USA., Moyzis RK; Department of Biological Chemistry, College of Medicine and Institute of Genomics and Bioinformatics, University of California, Irvine, Irvine, CA, USA.
Publikováno v:
Psychiatry research [Psychiatry Res] 2015 Jan 30; Vol. 231 (1), pp. 58-63. Date of Electronic Publication: 2014 Nov 04.
Autor:
Selen A; Office of New Drug Quality Assessment, US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland. Electronic address: arzu.selen@fda.hhs.gov., Dickinson PA; Quantitative Clinical Pharmacology, AstraZeneca, Macclesfield, UK., Müllertz A; Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark., Crison JR; Bristol-Myers Squibb, New Brunswick, New Jersey., Mistry HB; Physiomics PLC, Oxford, UK., Cruañes MT; Merck & Company, West Point, Pennsylvania., Martinez MN; US FDA/CVM, Rockville, Maryland., Lennernäs H; Department of Pharmacy, University of Uppsala, Uppsala, Sweden., Wigal TL; Child Development Center, University of California, Irvine, California., Swinney DC; iRND3, Mountain View, California., Polli JE; School of Pharmacy, University of Maryland, Baltimore, Maryland., Serajuddin ATM; College of Pharmacy and Health Sciences, St. John's University, Queens, New York., Cook JA; Pfizer Inc., Groton, Connecticut., Dressman JB; Institute of Pharmaceutical Technology Biocenter, Johann Wolfgang Goethe University, Frankfurt, Germany.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2014 Nov; Vol. 103 (11), pp. 3377-3397. Date of Electronic Publication: 2014 Sep 24.
Autor:
Volkow ND; National Institute on Drug Abuse, Bethesda, Maryland 20892, USA. nvolkow@nida.nih.gov, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2012 Jan 18; Vol. 32 (3), pp. 841-9.
Autor:
Volkow ND; National Institute on Drug Abuse, Bethesda, MD 20892, USA. nvolkow@nida.nih.gov, Wang GJ, Newcorn JH, Kollins SH, Wigal TL, Telang F, Fowler JS, Goldstein RZ, Klein N, Logan J, Wong C, Swanson JM
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2011 Nov; Vol. 16 (11), pp. 1147-54. Date of Electronic Publication: 2010 Sep 21.